These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 22407977

  • 1. Characterization of neutralizing affinity-matured human respiratory syncytial virus F binding antibodies in the sub-picomolar affinity range.
    Canziani GA, Melero JA, Lacy ER.
    J Mol Recognit; 2012 Mar; 25(3):136-46. PubMed ID: 22407977
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of a synthetic peptide as a replacement for the recombinant fusion protein of respiratory syncytial virus in a potency ELISA.
    McGivney JB, Bishop E, Miller K, Casas-Finet J, Yang H, Wei Z, Strouse R, Schenerman M.
    J Pharm Biomed Anal; 2011 Feb 20; 54(3):572-6. PubMed ID: 20943340
    [Abstract] [Full Text] [Related]

  • 3. Isolation of a neutralizing human RSV antibody from a dominant, non-neutralizing immune repertoire by epitope-blocked panning.
    Tsui P, Tornetta MA, Ames RS, Bankosky BC, Griego S, Silverman C, Porter T, Moore G, Sweet RW.
    J Immunol; 1996 Jul 15; 157(2):772-80. PubMed ID: 8752928
    [Abstract] [Full Text] [Related]

  • 4. Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoprotein.
    Crowe JE, Firestone CY, Crim R, Beeler JA, Coelingh KL, Barbas CF, Burton DR, Chanock RM, Murphy BR.
    Virology; 1998 Dec 20; 252(2):373-5. PubMed ID: 9878616
    [Abstract] [Full Text] [Related]

  • 5. Potent high-affinity antibodies for treatment and prophylaxis of respiratory syncytial virus derived from B cells of infected patients.
    Collarini EJ, Lee FE, Foord O, Park M, Sperinde G, Wu H, Harriman WD, Carroll SF, Ellsworth SL, Anderson LJ, Tripp RA, Walsh EE, Keyt BA, Kauvar LM.
    J Immunol; 2009 Nov 15; 183(10):6338-45. PubMed ID: 19841167
    [Abstract] [Full Text] [Related]

  • 6. Monoclonal antibody based in vitro potency assay as a predictor of antigenic integrity and in vivo immunogenicity of a Respiratory Syncytial Virus post-fusion F-protein based vaccine.
    Djagbare MD, Yu L, Parupudi A, Sun J, Coughlin ML, Rush BS, Sanyal G.
    Vaccine; 2018 Mar 14; 36(12):1673-1680. PubMed ID: 29456016
    [Abstract] [Full Text] [Related]

  • 7. Increased susceptibility of human respiratory syncytial virus to neutralization by anti-fusion protein antibodies on adaptation to replication in cell culture.
    Marsh R, Connor A, Gias E, Toms GL.
    J Med Virol; 2007 Jun 14; 79(6):829-37. PubMed ID: 17457900
    [Abstract] [Full Text] [Related]

  • 8. Antigenic Fingerprinting of Respiratory Syncytial Virus (RSV)-A-Infected Hematopoietic Cell Transplant Recipients Reveals Importance of Mucosal Anti-RSV G Antibodies in Control of RSV Infection in Humans.
    Fuentes S, Hahn M, Chilcote K, Chemaly RF, Shah DP, Ye X, Avadhanula V, Piedra PA, Golding H, Khurana S.
    J Infect Dis; 2020 Feb 03; 221(4):636-646. PubMed ID: 31745552
    [Abstract] [Full Text] [Related]

  • 9. [Plasmid construction, expression, immunogenicity and protective efficacy of recombinant protein candidate vaccine of respiratory syncytial virus].
    Zeng RH, Gong W, Fang XP, Zhang ZY, Mei XG.
    Sheng Wu Gong Cheng Xue Bao; 2005 Jul 03; 21(4):534-9. PubMed ID: 16176088
    [Abstract] [Full Text] [Related]

  • 10. Nanobodies® specific for respiratory syncytial virus fusion protein protect against infection by inhibition of fusion.
    Schepens B, Ibañez LI, De Baets S, Hultberg A, Bogaert P, De Bleser P, Vervalle F, Verrips T, Melero J, Vandevelde W, Vanlandschoot P, Saelens X.
    J Infect Dis; 2011 Dec 01; 204(11):1692-701. PubMed ID: 21998474
    [Abstract] [Full Text] [Related]

  • 11. Structure of a major antigenic site on the respiratory syncytial virus fusion glycoprotein in complex with neutralizing antibody 101F.
    McLellan JS, Chen M, Chang JS, Yang Y, Kim A, Graham BS, Kwong PD.
    J Virol; 2010 Dec 01; 84(23):12236-44. PubMed ID: 20881049
    [Abstract] [Full Text] [Related]

  • 12. Comparative binding of disulfide-bridged PEG-Fabs.
    Khalili H, Godwin A, Choi JW, Lever R, Brocchini S.
    Bioconjug Chem; 2012 Nov 21; 23(11):2262-77. PubMed ID: 22994419
    [Abstract] [Full Text] [Related]

  • 13. Monoclonal Antibodies Against the Human Respiratory Syncytial Virus Obtained by Immunization with Epitope Peptides and CpG-DNA-liposome Complex.
    Park BK, Choi SH, Kim YE, Park S, Lee Y, Lee KW, Kwon HJ.
    Monoclon Antib Immunodiagn Immunother; 2015 Apr 21; 34(2):101-9. PubMed ID: 25897608
    [Abstract] [Full Text] [Related]

  • 14. Antibody Fab display and selection through fusion to the pIX coat protein of filamentous phage.
    Tornetta M, Baker S, Whitaker B, Lu J, Chen Q, Pisors E, Shi L, Luo J, Sweet R, Tsui P.
    J Immunol Methods; 2010 Aug 31; 360(1-2):39-46. PubMed ID: 20600082
    [Abstract] [Full Text] [Related]

  • 15. Structure basis of neutralization by a novel site II/IV antibody against respiratory syncytial virus fusion protein.
    Xie Q, Wang Z, Ni F, Chen X, Ma J, Patel N, Lu H, Liu Y, Tian JH, Flyer D, Massare MJ, Ellingsworth L, Glenn G, Smith G, Wang Q.
    PLoS One; 2019 Aug 31; 14(2):e0210749. PubMed ID: 30730999
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
    Chen Y, Wiesmann C, Fuh G, Li B, Christinger HW, McKay P, de Vos AM, Lowman HB.
    J Mol Biol; 1999 Nov 05; 293(4):865-81. PubMed ID: 10543973
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Human monoclonal antibodies isolated from spontaneous Epstein-Barr virus-transformed tumors of Hu-SPL-SCID mice and specific for fusion protein display broad neutralizing activity toward respiratory syncytial virus.
    Chamat S, Walsh EE, Anderson D, Osta M, Awaraji C, Pan LZ, Ochi J, Shuey S, Brams P.
    J Infect Dis; 1999 Aug 05; 180(2):268-77. PubMed ID: 10395839
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.